Kenvue Inc. $KVUE Stock Position Lifted by Huber Capital Management LLC

Huber Capital Management LLC raised its stake in Kenvue Inc. (NYSE:KVUE) by 31.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 243,300 shares of the company’s stock after purchasing an additional 58,200 shares during the quarter. Huber Capital Management LLC’s holdings in Kenvue were worth $3,949,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Global Endowment Management LP lifted its stake in shares of Kenvue by 27.1% in the 3rd quarter. Global Endowment Management LP now owns 17,149 shares of the company’s stock valued at $278,000 after purchasing an additional 3,658 shares during the last quarter. Tocqueville Asset Management L.P. bought a new position in Kenvue during the third quarter valued at about $3,914,000. Johnson Financial Group Inc. raised its holdings in Kenvue by 277.8% during the third quarter. Johnson Financial Group Inc. now owns 5,062 shares of the company’s stock valued at $82,000 after buying an additional 3,722 shares in the last quarter. Quadrature Capital Ltd acquired a new stake in shares of Kenvue in the third quarter worth about $8,892,000. Finally, BNP Paribas Financial Markets boosted its stake in shares of Kenvue by 35.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,408,174 shares of the company’s stock worth $71,545,000 after acquiring an additional 1,142,819 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

Shares of NYSE KVUE traded up $0.12 during trading hours on Friday, hitting $17.51. 1,233,902 shares of the company’s stock were exchanged, compared to its average volume of 46,425,508. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The stock has a market capitalization of $33.57 billion, a price-to-earnings ratio of 22.76, a PEG ratio of 4.01 and a beta of 0.51. The company’s 50-day moving average price is $17.89 and its 200-day moving average price is $17.35.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The company’s revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.26 EPS. On average, sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is presently 107.79%.

Analyst Ratings Changes

A number of brokerages have recently commented on KVUE. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and lowered their price objective for the company from $23.00 to $18.00 in a report on Friday, January 30th. Argus raised Kenvue to a “hold” rating in a research report on Friday, March 6th. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Barclays lifted their price target on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Friday, March 6th. Finally, Citigroup upped their price objective on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. According to MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average target price of $19.58.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.